A REVIEW BASED ON DRUG REPURPOSING: AN VIRTUAL TOOL IN MODERN DRUG DISCOVERY

Drug repurposing involves using existing medications for new therapeutic purposes, gaining significant attention during the covid -19 pandemic as a means to expedite drug discovery and address urgent healthcare demands. The process starts with identifying potential drug candidates, followed by evaluating their effectiveness through preclinical models and advancing to phase2 clinical trials. identification can be achieved through both computational and experimental methods, leveraging public drug databases and various data sources, including primary research, clinical trials, and anecdotal evidence of off- label uses. Researchers utilize artificial intelligence and bioinformatics tools to explore drug –protein interactions, often integrating genetic information, clinical data, molecular docking, and other analyses to optimize outcomes. This article outlines the strategies for drug repurposing and list various drugs that have been successfully repurposed along with their new indications. Key words: drug repurposing, clinical trials, molecular docking, drug discovery, post- market safety

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-03
DOI
https://doi.org/10.5281/zenodo.14263909
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A REVIEW BASED ON DRUG REPURPOSING: AN VIRTUAL TOOL IN MODERN DRUG DISCOVERY

Zenodo (CERN European Organization for Nuclear Research)
Computational Drug Discovery Methods
article

A REVIEW BASED ON DRUG REPURPOSING: AN VIRTUAL TOOL IN MODERN DRUG DISCOVERY

article en

Abstract

Drug repurposing involves using existing medications for new therapeutic purposes, gaining significant attention during the covid -19 pandemic as a means to expedite drug discovery and address urgent healthcare demands. The process starts with identifying potential drug candidates, followed by evaluating their effectiveness through preclinical models and advancing to phase2 clinical trials. identification can be achieved through both computational and experimental methods, leveraging public drug databases and various data sources, including primary research, clinical trials, and anecdotal evidence of off- label uses. Researchers utilize artificial intelligence and bioinformatics tools to explore drug –protein interactions, often integrating genetic information, clinical data, molecular docking, and other analyses to optimize outcomes. This article outlines the strategies for drug repurposing and list various drugs that have been successfully repurposed along with their new indications. Key words: drug repurposing, clinical trials, molecular docking, drug discovery, post- market safety

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 53%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.